We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Intuitive Surgical (ISRG) Down 7.2% Since Last Earnings Report: Can It Rebound?
Read MoreHide Full Article
A month has gone by since the last earnings report for Intuitive Surgical (ISRG - Free Report) . Shares have lost about 7.2% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Intuitive Surgical due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.
Intuitive Surgical Q1 Earnings Miss Estimates, Grows Globally
Intuitive Surgical reported adjusted earnings of $2.61 per share in the first quarter of 2019, which fell short of the Zacks Consensus Estimate of $2.70. Adjusted earnings improved 7% year over year.
The company recorded revenues of $973.7 million which improved 14.9% from the prior-year quarter. However, the figure missed the Zacks Consensus Estimate of $980 million.
Segment Details
Instruments & Accessories
Revenues at the segment came in at $552.3 million, reflecting year-over-year increase of 20%. The improvement primarily reflects increased use of Intuitive Surgical’s advanced instruments.
Systems
In the reported quarter, System revenues increased 5.5% year over year to $247.5 million. Per management, Intuitive Surgical placed 235 da Vinci Surgical Systems in the first quarter compared with 185 systems in the year-ago quarter.
Per management, the install base of da Vinci systems expanded 13% on a year-over-year basis to approximately 5,110.
Services
Services revenues came in at $173.9 million, up 13.9% from the year-ago quarter.
International Sales Up
Outside the United States, revenues totaled $282 million, up 3% on a year-over-year basis but down 8% sequentially. The year-over-year improvement can be attributed to a greater proportion of da Vinci X systems and a higher mix of distributor arrangements.
Outside the United States, Intuitive Surgical placed 81 systems in the first quarter compared with 73 in the first quarter of 2019. Of these, 49 were in Europe, 13 in Japan, eight in Brazil and three in China.
Margins
Adjusted gross profit in the reported quarter was $692.9 million, up 14.2% year over year. As a percentage of revenues, adjusted gross margin in the quarter was 71.2%, down 40 basis points (bps).
Adjusted operating income totaled $361.5 million, up 4.4% year over year. As a percentage of revenues, adjusted operating margin in the quarter was 37.1%, down 380 bps.
2019 Outlook Impressive
Intuitive Surgical now forecasts 2019 procedure growth in the range of 15% to 17%, compared with the previous 13% to 17%.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in fresh estimates. The consensus estimate has shifted -10.26% due to these changes.
VGM Scores
At this time, Intuitive Surgical has a nice Growth Score of B, though it is lagging a lot on the Momentum Score front with a D. Following the exact same course, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Intuitive Surgical has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Intuitive Surgical (ISRG) Down 7.2% Since Last Earnings Report: Can It Rebound?
A month has gone by since the last earnings report for Intuitive Surgical (ISRG - Free Report) . Shares have lost about 7.2% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Intuitive Surgical due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.
Intuitive Surgical Q1 Earnings Miss Estimates, Grows Globally
Intuitive Surgical reported adjusted earnings of $2.61 per share in the first quarter of 2019, which fell short of the Zacks Consensus Estimate of $2.70. Adjusted earnings improved 7% year over year.
The company recorded revenues of $973.7 million which improved 14.9% from the prior-year quarter. However, the figure missed the Zacks Consensus Estimate of $980 million.
Segment Details
Instruments & Accessories
Revenues at the segment came in at $552.3 million, reflecting year-over-year increase of 20%. The improvement primarily reflects increased use of Intuitive Surgical’s advanced instruments.
Systems
In the reported quarter, System revenues increased 5.5% year over year to $247.5 million. Per management, Intuitive Surgical placed 235 da Vinci Surgical Systems in the first quarter compared with 185 systems in the year-ago quarter.
Per management, the install base of da Vinci systems expanded 13% on a year-over-year basis to approximately 5,110.
Services
Services revenues came in at $173.9 million, up 13.9% from the year-ago quarter.
International Sales Up
Outside the United States, revenues totaled $282 million, up 3% on a year-over-year basis but down 8% sequentially. The year-over-year improvement can be attributed to a greater proportion of da Vinci X systems and a higher mix of distributor arrangements.
Outside the United States, Intuitive Surgical placed 81 systems in the first quarter compared with 73 in the first quarter of 2019. Of these, 49 were in Europe, 13 in Japan, eight in Brazil and three in China.
Margins
Adjusted gross profit in the reported quarter was $692.9 million, up 14.2% year over year. As a percentage of revenues, adjusted gross margin in the quarter was 71.2%, down 40 basis points (bps).
Adjusted operating income totaled $361.5 million, up 4.4% year over year. As a percentage of revenues, adjusted operating margin in the quarter was 37.1%, down 380 bps.
2019 Outlook Impressive
Intuitive Surgical now forecasts 2019 procedure growth in the range of 15% to 17%, compared with the previous 13% to 17%.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in fresh estimates. The consensus estimate has shifted -10.26% due to these changes.
VGM Scores
At this time, Intuitive Surgical has a nice Growth Score of B, though it is lagging a lot on the Momentum Score front with a D. Following the exact same course, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Intuitive Surgical has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.